Genomtec is a MedTech company specializing in the development of advanced technologies in the field of genetic diagnostics. The company's flagship project is the Genomtec ID mobile diagnostic system, which allows for fast and precise molecular analysis outside the laboratory environment without the need to involve qualified laboratory personnel. The company has EU CE-IVD certification for the Genomtec ID RP5-PLEX diagnostic panel, which simultaneously detects the presence of the most common respiratory tract infections. The solution uses microfluidic technology and proprietary patented SNAAT® isothermal technology. The Genomtec technology is protected by 11 patents, for example, in Europe, the USA, and Japan, with over 35 patent pending applications on global markets. Genomtec's second project in oncology, "OncoSNAAT," consists of developing technology and a new automated system for mutation detection in the field of clinical oncology. This is based on a lab-on-chip solution and isothermal nucleic acid amplification techniques. The company's registered office is located in Wroclaw, Poland. Genomtec also has a branch in the UK, where part of the international research and engineering team is located. Genomtec combines confidence in molecular diagnostics with radical simplicity and cost reduction. The Genomtec team is a unique combination of experienced individuals from various fields with a common passion for creation. We work with a group of young, ambitious scientists and constructors. Everyday, we rely on our outstanding experienced scientists as well as our experts on commercialization and building and enforcing effective market strategies.